BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 19, 2025
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for July 23, 2025

July 23, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Astrazeneca, Biogen, Chengdu Kanghua, Hoth, Novo Nordisk.
Read More

Other news to note for July 22, 2025

July 22, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cardio Diagnostics, Intervene, SS Innovations International.
Read More

Other news to note for July 22, 2025

July 22, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Azurity, Concentra, Cycle, George, Handa, Iteos.
Read More

Other news to note for July 22, 2025

July 22, 2025
Additional early-stage research and drug discovery news in brief, from: Maia Biotechnology, Telomir Pharmaceuticals, Nanoviricides.
Read More

Other news to note for July 22, 2025

July 22, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: 365mc, Acumen, Biogen, Bridge Health, Centargia, Harrow, Hekabio, I-Mab, JCR, Kadimastem, Kowa, Nicox, Nkgen, NLS, Otsuka, Raziel, Samsung.
Read More

Other news to note for July 21, 2025

July 21, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Fluoguide, Olympus, Prophase, Radiology Oncology Systems, Raysearch, Zimvie.
Read More

Other news to note for July 21, 2025

July 21, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Blueprint Medicines, Hekabio, Nkgen, Sanofi.
Read More

Other news to note for July 18, 2025

July 18, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acer Medical, Deepqure, Foxo Technologies, Fujitsu, Inspira Technologies, Mentice.
Read More

Other news to note for July 18, 2025

July 18, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ajax, Amphista, Biogen, Blueprint, Bridge Health, Harrow, I-Mab, Itolerance, Kadimastem, Kowa, Merck, Molteni Farmaceutici, Nicox, NLS, Oncozenge, Samsung Bioepis, Sanofi, Schrödinger, Voyager.
Read More

Other news to note for July 18, 2025

July 18, 2025
Additional early-stage research and drug discovery news in brief, from: Aspect Biosystems, Enveric Biosciences, Canary Cure, Precision Biosciences.
Read More
Previous 1 2 … 21 22 23 24 25 26 27 28 29 … 1382 1383 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 18, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 18, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing